Singapore, Singapore

Olivier Nicolas Felix Cexus


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Olivier Nicolas Felix Cexus: Innovator in Health Status Identification

Introduction

Olivier Nicolas Felix Cexus is a notable inventor based in Singapore, recognized for his contributions to health diagnostics. He has developed a unique method for assessing the health status of elderly individuals through the identification of immunological biomarkers. His innovative approach has the potential to significantly enhance the understanding of health conditions in older populations.

Latest Patents

Cexus holds a patent titled "Identification of health status in the elderly using immunological biomarkers." This patent describes a method for determining the health status of elderly individuals by testing samples for the presence of specific biomarkers. The biomarkers include autoantibodies to various antigens, which can indicate healthy, intermediate, or unhealthy health statuses based on their presence.

Career Highlights

Throughout his career, Cexus has worked with prominent organizations such as Sengenics Corporation Pte Ltd and the Agency for Science, Technology and Research. His experience in these institutions has allowed him to refine his expertise in health diagnostics and biomarker research.

Collaborations

Cexus has collaborated with notable professionals in his field, including Jonathan Michael Blackburn and Arif Anwar. These partnerships have contributed to the advancement of his research and the development of innovative health assessment methods.

Conclusion

Olivier Nicolas Felix Cexus is a pioneering inventor whose work in identifying health status through immunological biomarkers is making a significant impact in the field of health diagnostics. His contributions are essential for improving the health management of elderly individuals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…